Translational Development Acquisition Corp.

translational-development.com

Translational Development Acquisition Corp. (TDAC) is a blank check company incorporated in 2022 and headquartered in New York. It has no significant operations and was formed to effect a business combination with one or more operating businesses.

In May 2026, TDAC announced a definitive agreement for a business combination with ProLogium, a developer of fourth-generation solid-state lithium ceramic batteries. The transaction values ProLogium at approximately $3.8 billion pre-money and is expected to close in the second half of 2026, subject to shareholder and regulatory approvals. Upon completion, the combined company would list on Nasdaq under the ticker PRLG.

Also known as TDAC and Translational Development Acquisition Corp. (TDAC).

Latest news on Translational Development Acquisition Corp.

24 September 2026
Mercedes‑Benz & ProLogium agree joint testing of Gen4 solid‑state battery cells

Priority access to a new Gen4 inorganic solid‑state cell; Mercedes will run electrical, thermal and safety trials to assess suitability for future EV platforms.

9 September 2026
ProLogium and Kyushu Electric Power deepen partnership with strategic investment

Existing partner shifts collaboration from industrial projects to capital participation, advancing plans for next‑generation battery module manufacturing in Japan for heavy‑duty electrification.

2 September 2026
ProLogium begins mass production of Gen 3.5 all‑solid‑state LCB — 381 Wh/kg, 903 Wh/L

185.4 Ah cell posts 381 Wh/kg and 903 Wh/L in TÜV test; UL vacuum test classifies it as all‑solid‑state. Gen 3.5 now in mass production at Taiwan gigafactory.

27 May 2026
ProLogium to list on Nasdaq via merger with Translational Development Acquisition Corp.

SPAC deal values company at ~$3.8B; will scale Gen‑4 solid‑state battery production, backed by up to ~€1.4B French subsidy, and target data‑center, aerospace and robotics markets.